[ibogaine] C.R.A.C.K

preston peet ptpeet at nyc.rr.com
Sun Jul 21 13:30:11 EDT 2002


Hey Howard,
Is this up online somewhere, with a link, so I can link to it at Drugwar.com?
Thanks.
peace,
Preston
  ----- Original Message ----- 
  From: HSLotsof at aol.com 
  To: ibogaine at mindvox.com 
  Sent: Saturday, July 20, 2002 10:54 PM
  Subject: [ibogaine] C.R.A.C.K


  Barbara Harris 
  Children Requiring A Caring Kommunity's 
  "Project Prevention" 
  P.O. Box 74 
  Stanton, CA 90680 

  Dear Ms. Harris: 

  We are writing to express our strong objections to your distribution of 
  highly misleading and completely inaccurate information regarding pregnant 
  women and methadone treatment. In a letter date February 22, 2002, you state, 
  in part: 

  "We are currently working with several methadone clinics that make our offer 
  known, and available, to the women and men who come through their program. 
  I'm sure one thing most can agree on is that it is important for those using 
  methadone or other drugs to refrain from getting pregnant." 

  We most certainly do not agree. Your statement, suggesting that it is 
  dangerous for a woman who is receiving clinically prescribed methadone 
  treatment to become pregnant, is simply wrong. Methadone is a highly 
  effective treatment for all opiate dependent patients and, most specifically, 
  for women - both before and after they may become pregnant. In fact, methadone
   treatment during pregnancy has not been associated with congenital 
  abnormalities or fetal demise. In those cases where neonatal withdrawal 
  symptoms occur (and they frequently do not), these symptoms can be treated 
  readily, with no evidence of any adverse impact on physical or cognitive 
  development. In short, there is simply no medical basis for your suggestion 
  that methadone patients should "refrain from getting pregnant." 

  For over 30 years, in countries throughout the world, methadone maintenance 
  treatment (MMT) has been shown to substantially reduce illegal opiate use and 
  the crime, illness, suffering, and death with which it is associated. The 
  benefits have been shown to accrue, not only to the individual patient, but 
  to his/her family and the community, as well. The most credible and objective 
  governmental and non-governmental organizations in America and abroad have 
  recognized these positive results with MMT. For example, the US Department of 
  Health and Human Services joins the scientific community in recognizing that 
  MMT greatly benefits the patients as well as the general community. It is 
  specifically recommended for pregnant and breast-feeding patients, which 
  further demonstrates the strong medical consensus supporting methadone 
  treatment, both in general and during pregnancy. 

  Unfortunately, despite methadone treatment's many benefits, it is available 
  to fewer than 20% of the people who most need it. Women, in particular, face 
  numerous barriers to obtaining this important medical intervention. Your 
  letter and activities, which spread false information and stigmatize current 
  and future mothers who receive this treatment, will make it even more 
  difficult for women who need methadone treatment to receive it. 

  We therefore urge you to withdraw this letter immediately and to advise each 
  of those individuals and clinics who received it that it was based on 
  misinformation. Furthermore, it is essential that you publicly repudiate the 
  inaccurate message you conveyed on your organization's website and in other 
  public and media context. Not to do so would be irresponsible and a great 
  disservice to those whose interests you claim to have at heart. 

  Signed, 


  Signatories 

  1. Lynn Singer, Ph.D, Professor of Pediatrics and Psychiatry, Case Western 
  Reserve University, School of Medicine 
  2. Stephen Kandall, MD, Retired Professor of Pediatrics, Albert Einstein 
  College of Medicine 
  3. Daniel Neuspiel, MD, MPH, Associate Chairman of Pediatrics, Beth Israel 
  Medical Center 
  4. Robert Newman, MD, Director, Baron Edmond de Rothschild Chemical 
  Dependency Institute of Beth Israel Medical Center 
  5. Barry Lester, Ph.D., Director, Infant Development Center, Women and 
  Infants’ Hospital 
  6. Mary Faith Marshall, Ph.D., Professor of Medicine and Bioethics, Kansas 
  University Medical Center 
  7. Maryann Amodeo, Ph.D., Professor, Boston University School of Social Work, 
  Alcohol and Drug Institute for Policy, Research and Training 
  8. Denise Paone, Ph.D., Evaluation and Training Consultant, Former Assistant 
  Director of Research, Chemical Dependency Institute, Beth Israel Medical 
  Center 
  9. John J. Botti, MD, Director, Maternal Fetal Medicine, Penn State Hershey 
  Medical Center 
  10. Mary Mahowald, Ph.D., Professor, Dept. of OB/GYN, University of Chicago 
  11. Machelle Allen, MD, Assistant Professor, Department of OB/GYN, NYU School 
  of Medicine 
  12. Wendy Chavkin, MD, MPH, Clinical Professor of Public Health and OB/GYN, 
  Columbia University, Mailman School of Public Health 
  13. Marjorie Greenfield MD, Associate Professor of OB/GYN, University 
  Hospitals of Cleveland, Case Western Reserve University School of Medicine 
  14. Hytham Imseis, MD, Mountain Area Health Education Center, Dept. of OB/GYN 
  15. Dona Upson, MD, Associate Professor of Medicine, University of New Mexico 
  16. Mack Lipkin, Jr., MD, Director of Primary Care, NYU School of Medicine 
  17. Ernest Drucker, Ph.D., Professor of Epidemiology and Social Medicine, 
  Montefiore Medical Center/Albert Einstein School of Medicine 
  18. Angela R. Holder, LLM, Professor of the Practice of Medical Ethics, 
  Center for the Study of Medical Ethics and Humanities, Duke University 
  Medical Center 
  19. Sydney L. Hans, Ph.D., Research Associate Professor, Department of 
  Psychiatry, University of Chicago 
  20. Craig Reinarman, Ph.D., Chair and Professor, Dept. of Sociology, UC Santa 
  Cruz 
  21. Rachel Roth, Ph.D., Assistant Professor, Washington University 
  22. Monica J. Casper, Ph.D., Associate Professor of Sociology, UC Santa Cruz 
  23. Anthony R. Kovner, Ph.D., Professor of Health Policy and Management, 
  Wagner/NYU 
  24. Susan L. Adams, Ph.D., RN, Associate Professor of Nursing, Women’s 
  Health Nurse Practitioner, Perinatal Addiction, Dominican University of 
  California 
  25. Nina Peskoe Peyser, Former Executive Director of the Chemical Dependency 
  Institute at Beth Israel Medical Center 
  26. Holly Catania, Baron Edmond de Rothschild Chemical Dependency Institute 
  of Beth Israel Medical Center 
  27. Nancy D. Campbell, Ph.D., Assistant Professor, Rensselaer Polytechnic 
  Institute 
  28. Jerome Richardson, Assistant Professor, University of Illinois at Chicago 
  29. Karyn L. Pomerantz, MLS, MPH, GW School of Public Health & Health 
  Services 
  30. Janet Lynne Golden, Ph.D., Associate Professor, Rutgers University 
  31. Cynthia Daniels, Ph.D., Associate Professor, Rutgers University 
  32. Drew Humphries, Ph.D., Department of Sociology, Anthropology and Criminal 
  Justice, 
  Rutgers University 
  33. Elizabeth M. Armstong, Ph.D., Assistant Professor, Princeton University 
  34. Jael Silliman, Ed.D., Associate Professor, University of Iowa 
  35. Jeanne Flavin, Ph.D., Associate Professor, Fordham University 
  36. Victor J. Bernstein, Ph.D., Associate Professor, University of Chicago 
  37. Grace Chang, Ph.D., Evergreen State College 
  38. Mario A. Caro, Ph.D. Candidate, Professor, Evergreen State College 
  39. Phillip Coffin, MIA, Project Director, Center for Urban Epidemiologic 
  Studies, New York Academy of Medicine 
  40. Sheigla Murphy, Ph.D., Institute for Scientific Analysis 
  41. Leslie D. McCrory, Clinical Supervisor, Health Partners 
  42. Ann D. Brown, CNM, MSN, Dept. of OB/GYN, Mountain Area Health Education 
  Center 
  43. Shelley Galvin, MA, Research & Grants Coordinator, Dept. of OB/GYN, 
  Mountain Area Health Education Center 
  44. Susan Shinn, RNC, Women’s Health, Mountain Area Health Education 
  Center 
  45. Melissa McClure, Medical Records Coordinator, Mountain Area Perinatal 
  Substance Abuse Program 
  46. Cheryl Timbs, Clinical Supervisor, Mountain Area Perinatal Substance 
  Abuse Program 
  47. Elizabeth Finger, LWW, Director of Behavior Medicine, Mountain Area 
  Health Education Center 
  48. Terry Sutton, Program Assistant, Mountain Area Health Education Center 
  49. Jean Cassidy, Dept. of OB/GYN, Mountain Area Health Education Center 
  50. Steve Allison, Certified Clinical Addiction Specialist, Mountain Area 
  Health Education Center 
  51. Gregory McCoy, Mountain Area Perinatal Substance Abuse Program 
  52. Michael Eisenberg, MD, MPH, President, ASPIRE 
  53. Luciano Colonna, Executive Director, Harm Reduction Project 
  54. Michael R. Aldrich, Ph.D 
  55. Ivan Zimmerman, J.D. 
  56. Rickie Solinger, Ph.D., Historian 
  57. National Women's Health Network 
  58. National Black Women’s Health Project 
  59. National Association for Public Health Policy Council on Illicit Drugs 
  60. Institute for Health and Recovery 
  61. Advocates for Recovery through Medicine (ARM) 
  62. Advocates for Recovery through Medicine (ARM) of Arkansas & Oklahoma 
  63. Advocates for Recovery through Medicine (ARM) of DC 
  64. Connecticut Women’s Consortium 
  65. Casa Segura 
  66. Lower East Side Harm Reduction Center 
  67. Addiction Treatment Watchdog 
  68. CAP Quality Care Methadone Clinic 
  69. Virginia Alliance of Methadone Advocates 
  70. Vermont Harm Reduction Coalition 
  71. San Francisco AIDS Foundation HIV Prevention Project 
  72. AIDS Project New Haven 
  73. HIV Law Project 
  74. ASPIRE 
  75. Drug Policy Alliance 
  76. Urban Justice Center 
  77. Criminal Justice Policy Institute 
  78. Center for Human Rights Education 
  79. Family Watch 
  80. Committee on Women, Population, and the Environment 
  81. Cambridge Cares About AIDS 
  82. California Coalition for Women Prisoners 
  83. Legal Services for Prisoners With Children 
  84. NORML Foundation 
  85. Common Sense for Drug Policy 
  86. Drug Policy Forum of Hawaii 
  87. ReconsiDer 
  88. Communities Against Rape and Abuse 
  89. Mikki Norris, Human Rights and the Drug War 
  90. Alice Diorio, President, Vermont Harm Reduction Coalition 
  91. Kevin Zeese, Executive Director, Common Sense for Drug Policy 
  92. Donna M. Shea, Legal Director, NORML 
  93. Mark Beresky, Secretary/Treasurer, Vermont Harm Reduction Coalition 
  94. Marc Shinderman, MD, CAP Quality Care Methadone Clinic 
  95. Cassie Pierson, Staff Attorney, Legal Services for Prisoners with 
  Children 
  96. Monique Tula, Director of Harm Reduction Services, Cambridge Cares About 
  AIDS 
  97. Eliza Wheeler, Needle Exchange Program Coordinator, Cambridge Cares About 
  AIDS 
  98. Robin Clark-Smith, AIDS Program, Bridgeport Health Department 
  99. Terri Bogage, Institute for Health and Recovery 
  100. Syd Lindsley, Committee on Women, Population, and the Environment 
  101. Jacqueline Robarge, Power Inside 
  102. Stephanie Manfre, Children’s Case Manager, Riley Center 
  103. Ann Beck, Riley Center 
  104. Jennifer Grant, Director, Riley Center 
  105. Teresa Martyny, Riley Center 
  106. Kylie Chow, Brennan House 
  107. JoAnn Yang, Riley Center 
  108. Michelle Rivera, Riley Center 
  109. Carolina Alaniz, Riley Center 
  110. Idoia Irastorza, Riley Center 
  111. Megan Koroshetz, Riley Center 
  112. Stacy Benedict, Riley Center 
  113. Liliana Diaz, San Francisco Department of Public Health 
  114. Ellenie Tuazon, San Francisco Department of Public Health 
  115. Elba Warner, San Francisco Department of Public Health 
  116. Ebone Colbert, Communities Against Rape and Abuse 
  117. Theryn Kigvamasud’Vashti, Communities Against Rape and Abuse 
  118. Alisa Bierria, Program Coordinator, Communities Against Rape and Abuse 
  119. Shane Felles 
  120. Brion Roberts 
  121. Susan Yanow, Director, Abortion Access Project 
  122. Shiela VanDerveer, Development Director, NARAL – NH 
  123. NOW Legal Defense and Education Fund 
  124. Marsha Rosenbaum, Ph.D., Director, Safety First Project, Drug Policy 
  Alliance 
  125. Ann M. Boyer, MD, MS, Mt. Sinai Medical Center 
  126. Nancy Mamis-King, Associate Executive Director, Neighborhood Youth & 
  Family Services 
  127. Maureen Denman, Atlantic Health System 
  128. Shelly Carter, Health Educator, New Mexico Prenatal Care Network, 
  University of New Mexico 
  129. National Council on Alcoholism & Drug Dependence 
  130. Gloria Knighton 
  131. Virginia Nurses Society on Addictions 
  132. National Alliance of Methadone Advocates 
  133. National Advocates for Pregnant Women
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://www.mindvox.com/pipermail/ibogaine/attachments/20020721/1ff07736/attachment.html>


More information about the Ibogaine mailing list